TrialSpark is a pioneering brand that aims to revolutionize the world of clinical trials. With a focus on innovation and efficiency, TrialSpark's teams and cutting-edge technology dramatically accelerate the process of conducting clinical trials. Founded by CEO Ben Liu, TrialSpark leverages machine learning, AI, and big data to develop diagnostics and therapeutics for diseases like Parkinson's and Alzheimer's.

Liu's firsthand experience with the bottlenecks faced during clinical trials inspired him to create TrialSpark. Working alongside Liu is Linhao Zhang, the Chief Operating Officer, who oversees the company's product development, engineering, and operations teams. Together, they ensure operational excellence and drive the company's strategic initiatives in clinical development.

Gavin Corcoran, the Chief Development Officer, brings his expertise in scientific and medical input to the drug development process. With years of experience in regulatory approval and clinical trial oversight, Corcoran plays a pivotal role in TrialSpark's success. Joining the leadership team is James Leslie, the Chief Financial Officer, who brings a wealth of experience from the healthcare, insurance, and education sectors.

His financial acumen helps support TrialSpark's growth and stability. Sabrina Comic-Savic, the Head of Quality Assurance, ensures that TrialSpark maintains the highest standards of quality in their clinical development activities. With her extensive background in quality management, Sabrina plays a crucial role in guaranteeing the reliability and accuracy of TrialSpark's trials.

Melissa Enbar, the Chief People Officer, leads the People Operations, Talent, and Legal departments, focusing on creating a diverse and inclusive environment that fosters individual growth and success. Drawing from her experience at leading organizations like Birchbox and Harvard Business School, Enbar ensures TrialSpark attracts and retains top talent. With its dedication to innovation, efficiency, and quality, TrialSpark is transforming the clinical trial landscape, bringing new hope to patients and revolutionizing the future of medicine